dcgi

Bengaluru: Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19. Favipiravir has received authorisation from the Drug Controller…
Read More...

Bengaluru: In a rather positive development amid the pandemic situation, Hyderabad-bassed Bharat Biotech has begun the human trials of COVAXIN, India’s first indigenous vaccine candidate the coronavirus infection, and all three subjects so…
Read More...